Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases.
$2.36
As of 03/02/2021 IEX book CBOE book
2021 © Stock Market MBA, Inc.